Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials?
Naylor CD, Llewellyn-Thomas HA. J Clin Epidemiol. 1994; 47(7):787-95.
Naylor CD, Llewellyn-Thomas HA. J Clin Epidemiol. 1994; 47(7):787-95.
Chen E, Naylor CD. Med Care. 1994; 32(5):420-35.
Hux JE, Levinton CM, Naylor CD. J Gen Intern Med. 1994; 9(4):195-201.
Goel V. Can J Public Health. 1994; 85(2):125-7.
Naylor CD, McGlynn EA, Leape LL, Pinfold SP, Bernstein SJ, Hilborne LH, Park RE, Kahan JP, Brook RH. Can J Cardiol. 1994; 10(1):41-8.
Naylor CD, Levinton CM, Wheeler S, Hunter L. Soc Sci Med. 1993; 37(1):61-7.
Anderson GM, Grumbach K, Luft HS, Roos LL, Mustard C, Brook R. JAMA. 1993; 269(13):1661-6.
Naylor CD, Williams JI, Basinski A, Goel V. CMAJ. 1993; 148(6):921-4.
Anderson GM, Kerluke KJ, Pulcins IR, Hertzman C, Barer ML. Inquiry. 1993; 30(2):199-207.